[Etofibrate and clofibrate in double blind study].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002995:Clofibric Acid / Q000031:analogs & derivatives; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos
D000924:Anticholesteremic Agents; D009539:Nicotinic Acids; D010919:Placebos; C009746:etofibrate; D002995:Clofibric Acid; D002994:Clofibrate
Etofibrat und Clofibrat im Doppelblindversuch